Cargando…
Vaccine-induced immune thrombotic thrombocytopenia
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is primarily a complication of adenoviral vector-based covid-19 vaccination. In VITT, thrombocytopenia and thrombosis mediated by anti-platelet factor 4 (PF4) antibodies can be severe, often characterized by thrombosis at unusual sites such a...
Autores principales: | Kanack, Adam J., Padmanabhan, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467921/ https://www.ncbi.nlm.nih.gov/pubmed/36494147 http://dx.doi.org/10.1016/j.beha.2022.101381 |
Ejemplares similares
-
COVID‐19 mRNA‐1273 vaccine induces production of vaccine‐induced immune thrombotic thrombocytopenia antibodies
por: Padmanabhan, Anand, et al.
Publicado: (2022) -
Persistence of Ad26.COV2.S‐associated vaccine‐induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies
por: Kanack, Adam J., et al.
Publicado: (2022) -
Vaccine-induced immune thrombotic thrombocytopenia
por: Klok, Frederikus A, et al.
Publicado: (2022) -
Vaccine-induced immune thrombotic thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2023) -
Vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Warkentin, Theodore E.
Publicado: (2022)